CATEGORIES

Sydney University strengthens international ties in research and innovation

New international opportunities are open to Sydney researchers and students as the University expands partnership agreements with the University of Glasgow, Scotland and the University of California San Diego, US

WHO certifies Azerbaijan and Tajikistan as malaria-free

The World Health Organisation (WHO) has certified Azerbaijan and Tajikistan for achieving elimination of malaria in their territories

Fujitsu launches new cloud-based platform for healthcare in Japan

Fujitsu has announced the launch of a new cloud-based platform that allows users to securely collect and leverage health-related data to promote digital transformation in the medical field

Takeda to invest ¥100 B in new facility for plasma-derived therapies in Japan

Takeda Pharmaceutical will invest approximately 100 billion yen (Y) to build a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan

Singapore gives nod to first smart wearable stethoscope

Aevice Health, a Singapore-based medtech startup that specialises in developing remote respiratory monitoring solutions, has announced that its flagship medical device, the AeviceMD Monitoring System, has received approval from the Health Sciences Authority of Singapore (HSA).

Australia announces world first framework for rural and remote nursing

A world-first guide addressing the unique demands and challenges for Registered Nurses in rural and regional Australia has been released

India exempts full customs duty on all drugs used in rare diseases treatment

The Government of India has given full exemption from basic customs duty on all drugs and food for special medical purposes imported for personal use for treatment of all rare diseases listed under the National Policy for Rare Diseases 2021 through a general exemption notification

$15B Pharma R&D Spends ROCKS APAC

Earlier seen as a generic powerhouse, Asia is now an important hub for pharma R&D innovation

The Key To A Precision Medicine Future: AI Plus Human Ingenuity

Artificial intelligence (AI) is being used to find new promising targets and design new molecules to treat diseases. It is also being applied in the optimisation of the clinical trial process – analysing data to predict outcomes to help prevent timely and costly late-stage failures, and producing health digital twins to speed up trials, and precision public health. It’s very possible to imagine a data-driven, streamlined, precision medicine future merging the best of human and machine intelligence to manage our individual health in ways we never previously imagined.

"Immutep has started exploring the potential of the first ever triple combination therapy with Eftilagimod"

Australian firm Immutep has partnered with Merck and Pfizer for a new Phase I clinical study in patients with urothelial cancer for its lead product candidate -eftilagimod, in combination with avelumab (BAVENCIO).

"APAC continues to be a global hub for clinical trials"

The Asia Pacific (APAC) represents more than a third of all cell and gene therapy in global trials.

Addressing 'Orphaning' of Rare Diseases

To tackle any disease requires sustained research and development (R&D), to help us learn more about it and to create effective treatments. However, when it comes to R&D around rare diseases, there are few key challenges which ultimately impact patient outcomes.

"India is now working on the target of ending TB by 2025"

Noting the declining number of Tuberculosis (TB) patients, India resolved to eliminate TB by 2025 as against the global target of 2030.

A World Sans MALARIA

Malaria has long been a major public health concern in the Asia Pacific region, particularly in South East Asia (SEA) affecting millions of people.

Scientists In New Zealand Identify Drug That Could Extend Lifespan

The age-old quest for immortality has taken a step forward with the results of a New Zealand study recently published by the researchers at the University of Auckland.

How Plausible Is Ending TB Scourge?

Despite countries making bold commitments to end TB by 2030, in the Sustainable Development Goals, the WHO End TB Strategy and the 2018 political declaration on the fight against TB, the epidemic shows no sign of slowing down.

Can Med Tourism Industry Hit Goldmine With Robot-Assisted Surgery?

The quality of Healthcare is projected to become enhanced in the future, aided by new innovations in technology.

Sciex expands protein characterisation capabilities

Sciex, a US-based leader in life science analytical technologies, has announced the launch of the Fast Glycan Labeling and Analysis kit for quantitative glycan analysis  and an update for Biologics Explorer software to enhance critical protein therapeutic analysis workflows.

Korea designs smart contact lens for diagnosing and treating glaucoma

A research team at Pohang University of Science and Technology (POSTECH) in South Korea has developed a smart contact lens by combining an intraocular pressure (IOP) sensor and a flexible drug delivery system to manage IOP measurement and medication administration in glaucoma patients.

World Health Organisation releases new Global Breast Cancer Initiative Framework

The World Health Organisation (WHO) has released a new Global Breast Cancer Initiative Framework providing a roadmap to attain the targets to save 2.5 million lives from breast cancer by 2040.

CEPI collaborates to advance tools for Sudan ebolavirus vaccine research

The Coalition for Epidemic Preparedness Innovations (CEPI) is supporting the development of an international antibody standard against Sudan ebolavirus (SUDV)

Global Fund provides $867M in additional funding for pandemic preparedness and response

Since December 2022, the Global Fund has awarded $547 million in additional funding to 40 countries through its COVID-19 Response Mechanism (C19RM) and has now initiated the process to award a further $320 million, making a total of approximately $867 million.

The New Pandemic Of Layoffs

Employees across various sectors have been hit hard due to various restructuring measures leading to layoffs.

Formosa Pharma inks agreement with Eyenovia for new ophthalmic therapies

Taiwan-based Formosa Pharmaceuticals has entered into a collaboration agreement with US-based Eyenovia, for the development of novel ophthalmic therapeutics.

Eli Lilly ensures patient access to high-quality affordable insulin in Bangladesh

American pharmaceutical firm Eli Lilly and Company will supply its active pharmaceutical ingredient (API) for human insulin at a reduced price to International Agencies (Bangladesh) Ltd.

Daewoong inks $336M deal with CS Pharma for Idiopathic Pulmonary Fibrosis treatment

South Korea’s Daewoong Pharmaceutical has secured an exclusive licensing agreement with CS Pharmaceuticals,

Gavi and India join hands to protect children with life-saving vaccines

Gavi, the Vaccine Alliance, and the Government of India have established a new three-year partnership that aims to reach millions of children in the country with life-saving vaccines.

China approves AI software to assess symptoms of Parkinson's disease

Nervtex's MoDAS artificial intelligence (AI) system has become the first video-based, AI-powered medical device to win regulatory approval for assessing motor symptoms in Parkinson's disease and other movement disorders, according to a company press release.

APAC Fem Tech Space Gains Momentum

Do you know what takes the blame for a woman’s bad health? Oestrogen, as it is the hormone that plays a central role in women’s health.

Can India Eliminate TB by 2025?

Tuberculosis (TB) is a severe public health issue in India, accounting for a quarter of the global TB burden.